stockrow
Friday 6 November 2026
Export BGM’s income statement to Excel — free account
BGM Group Ltd.
BGM Healthcare Drug Manufacturers Specialty & Generic
BGM Group Ltd.’s revenue for fiscal 2025 (year ended September 2025) was $37.9 million, up 51.1% from fiscal 2024.
8.25
0.75
−8.33%
Follow BGM
Alert me
BGM Group Ltd. (BGM) P/E ratio
As of 5 November 2026, BGM Group Ltd. (BGM) trades at a P/E ratio of 148×. Over the past ten years it has ranged from 8.8× (April 2021) to 8,181× (June 2025); the current reading is higher than 13% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 20.5× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 5,121× | 28.16% |
| FY2024 | 3,995× | 102.96% |
| FY2023 | 1,969× | 32.32% |
| FY2022 | 1,488× | 0.00% |
| FY2021 | 1,488× | 6,892.03% |
| FY2020 | 21.3× | 0.00% |
| FY2019 | 21.3× | 0.00% |
| FY2018 | 21.3× | 0.00% |
| FY2017 | 21.3× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Mar 2023 | 108× | 117.82% |
| Sep 2022 | 49.6× | 0.00% |
| Mar 2022 | 49.6× | 0.00% |
| Sep 2021 | 49.6× | 400.62% |
| 1 more quarters | Free account |
Against its own ten years
Low 8.8×
High 8,181×
Ten-year median
1,905×
Current reading's percentile
13
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SIGA Siga Technologies Inc. compare | n/m |
| ADCT ADC Therapeutics SA compare | n/m |
| DERM Journey Medical Corporation compare | n/m |
| GLAS Glass House Brands Inc. compare | n/m |
| AKBA Akebia Therapeutics, Inc. compare | n/m |
| ORGO Organogenesis compare | n/m |
| CRDL Cardiol Therapeutics Inc. compare | n/m |
| OGI Organigram Global Inc. compare | 2.0× |
| BGM BGM Group Ltd. | 148× |
| Drug Manufacturers Specialty & Generic industry median | 20.5× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)